StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the stock. BiondVax Pharmaceuticals Stock Down 0.5 % BVXV stock opened at $1.21 on Friday. The company’s 50 day moving average price is $1.24 and its 200 day […]
